Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plozasiran in Adults With Mixed Dyslipidemia
NCT04998201Phase 2Completed
- Sponsor
- Arrowhead Pharmaceuticals
- Start
- Sep 2021
- Primary completion
- Feb 2023
- Modality
- Conjugated siRNA, Chemically Modified siRNA
- Countries
- 6
01
Overview
A Phase 2 trial of plozasiran in mixed dyslipidemia, sponsored by Arrowhead Pharmaceuticals. Started Sep 2021; status: completed.
02
Drugs
plozasiran
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT04998201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04998201.